• 1
    Zouboulis CC. Epidemiology of Adamantiades-Behçet's disease. Ann Med Interne (Paris) 1999; 150: 48898.
  • 2
    Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341: 128491.
  • 3
    Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 41122.
  • 4
    Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3: 14855.
  • 5
    Yazici H, Yurdakul S, Hamuryudan V. Behçet's syndrome. In: KlippelJH, DieppePA, editors. Rheumatology. Vol. 7: 26. London: Mosby; 1998. p. 16.
  • 6
    Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behçet's disease: an international collaborative study. Br J Ophthalmol 2007; 91: 157982.
  • 7
    Houman MH, Neffati H, Braham A, Harzallah O, Khanfir M, Miled M, et al. Behçet's disease in Tunisia: demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol 2007; 25(4 Suppl 45 ): S5864.
  • 8
    Joseph FG, Scolding NJ. Neuro-Behçet's disease in Caucasians: a study of 22 patients. Eur J Neurol 2007; 14: 17480.
  • 9
    Ehrlich GE. Vasculitis in Behçet's disease. Int Rev Immunol 1997; 14: 818.
  • 10
    Lewis KA, Graham EM, Stanford MR. Systematic review of ethnic variation in the phenotype of Behçet's disease. Scand J Rheumatol 2007; 36: 16.
  • 11
    Azizlerli G, Kose AA, Sarica R, Gul A, Tutkun IT, Kulac M, et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003; 42: 8036.
  • 12
    Koumantaki Y, Stavropoulos C, Spyropoulou M, Messini H, Papademetropoulos M, Giziaki E, et al. HLA-B*5101 in Greek patients with Behçet's disease. Hum Immunol 1998; 59: 2505.
  • 13
    Salvarani C, Pipitone N, Catanoso MG, Cimino L, Tumiati B, Macchioni P, et al. Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 2007; 57: 1718.
  • 14
    Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999; 54: 21320.
  • 15
    Jankowski J, Crombie I, Jankowski R. Behçet's syndrome in Scotland. Postgrad Med J 1992; 68: 56670.
  • 16
    Ambresin A, Tran T, Spertini F, Herbort C. Behçet's disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 2002; 10: 5363.
  • 17
    Calamia K, Mazlumzadeh M. Behçet's disease. Bull Rheum Dis 2004; 53: 18.
  • 18
    Okada AA. Behçet's disease: general concepts and recent advances. Curr Opin Ophthalmol 2006; 17: 5516.
  • 19
    Zouboulis CC, Diawari D, Kirch W, Ochsendorf FR, Keitel W, Licht-Mbalyonere A. Adamantiades-Behçet's disease in Germany: data of the German registry in 1966. In: VIIth International Conference on Behçet's Disease [abstract]. Rev Rhum Engl Ed 1996; 63: 538.
  • 20
    Nakae K, Masaki F, Hashimoto T, Inaba G, Mochizuki M, Sakane T. Recent epidemiological features of Behçet's disease in Japan. In: WechslerB, GodeauP, editors. Behçet's disease. Amsterdam: Excerpta Medica; 1993.
  • 21
    O'Duffy JD. Summary of international symposium on Behçet's disease: Istanbul, September 29–30, 1977. J Rheumatol 1978; 5: 22933.
  • 22
    Teter MS, Hockberg MC. Diagnostic criteria and epidemiology. In: CalabroJJ, PlotkinGR, O'DuffyJD, editors. Behçet's disease: a contemporary synopsis. Mount Kisko (NY): Futura; 1988. p. 15.
  • 23
    O'Duffy JD. Behçet's disease. Curr Opin Rheumatol 1994; 6: 3943.
  • 24
    Melton L. History of the Rochester Epidemiology Project. Mayo Clin Pro 1996; 71: 26674.
  • 25
    International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease [review]. Lancet 1990; 335: 107880.
  • 26
    Schroeder DJ, Offord KP. A SAS macro which utilizes local and reference population counts appropriate for incidence, prevalence, and mortality rate calculations in Rochester and Olmsted County, Minnesota. Technical report series: section of medical research statistics, report no: 20. Rochester (MN): Mayo Clinic; 1982.
  • 27
    Muhaya M, Lightman S, Ikeda E, Mochizuki M, Shaer B, McCluskey P, et al. Behçet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 2000; 8: 1418.
  • 28
    Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behçet's disease. Semin Arthritis Rheum 1998; 27: 197217.
  • 29
    Chung YM, Yeh TS, Sheu MM, Chen MS, Wen MS, Tsai HY, et al. Behçet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 1990; 89: 4137. In Chinese.
  • 30
    Al-Dalaan AN, al Balaa SR, el Ramahi K, al-Kawi Z, Bohlega S, Bahabri S, et al. Behçet's disease in Saudi Arabia. J Rheumatol 1994; 21: 65861.
  • 31
    Al-Araji A, Sharquie K, al-Rawi Z. Prevalence and patterns of neurological involvement in Behçet's disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 2003; 74: 60813.
  • 32
    Yazici Y, Erkan D, Ince A, Nesher G, Kural E, Seyahi N, et al. Behçet's disease: does lack of knowledge result in under-diagnosis? [abstract]. Clin Exp Rheumatol 2004; 22(4 Suppl 34 ): 812.